ARTA
BIO icon

A.R.T. Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

A.R.T. Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,800
Closed -$2.89M – 160
2019
Q4 		$2.89M Buy
7,800
+6,200
+388% +$2.19M 0.14% 187
2019
Q3 		$532K Buy
1,600
+500
+45% +$163K 0.03% 833
2019
Q2 		$344K Sell
1,100
-8,200
-88% -$2.46M 0.02% 896
2019
Q1 		$2.84M Buy
9,300
+5,300
+133% +$1.43M 0.17% 151
2018
Q4 		$929K Sell
4,000
-6,000
-60% -$1.61M 0.06% 466
2018
Q3 		$3.13M Buy
10,000
+7,000
+233% +$2.17M 0.14% 188
2018
Q2 		$865K Sell
3,000
-800
-21% -$221K 0.04% 698
2018
Q1 		$950K Buy
3,800
+2,000
+111% +$509K 0.04% 685
2017
Q4 		$429K Sell
1,800
-400
-18% -$96.9K 0.02% 958
2017
Q3 		$488K Sell
2,200
-3,900
-64% -$878K 0.02% 836
2017
Q2 		$1.38M Sell
6,100
-9,300
-60% -$2.03M 0.07% 381
2017
Q1 		$3.07M Buy
+15,400
New +$2.97M 0.14% 194
2016
Q4 		– Sell
-2,400
Closed -$393K – 1281
2016
Q3 		$393K Buy
+2,400
New +$364K 0.13% 249
2015
Q4 		– Sell
-5,498
Closed -$738K – 1466
2015
Q3 		$738K Sell
5,498
-2,986
-35% -$430K 0.03% 735
2015
Q2 		$1.28M Buy
+8,484
New +$1.21M 0.04% 630
2014
Q4 		– Sell
-6,758
Closed -$766K – 1423
2014
Q3 		$766K Sell
6,758
-2,043
-23% -$242K 0.04% 592
2014
Q2 		$1.05M Buy
+8,801
New +$1.07M 0.05% 487
2013
Q3 		– Sell
-2,169
Closed -$243K – 1305
2013
Q2 		$243K Buy
+2,169
New +$254K 0.01% 1108

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

A.R.T. Advisors's BIO Position: Q1 2020 in Review

A.R.T. Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2020, closing a stake of 7,800 shares — an estimated $2.89M sold.

A.R.T. Advisors first reported a position in BIO in Q2 2013 and held it in 18 quarters. The position peaked at $3.13M in Q3 2018. 406 funds tracked by Wall St. Rank hold BIO as of Q1 2020.

  • A.R.T. Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 7,800 Bio-Rad Laboratories Class A shares in Q1 2020, an estimated $2.89M.
  • A.R.T. Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 18 quarters.
  • A.R.T. Advisors's Bio-Rad Laboratories Class A position peaked at $3.13M in Q3 2018.
  • 406 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.